Pharming Group (PHAR)
9.15
+0.22
(+2.46%)
USD |
NASDAQ |
May 31, 16:00
9.105
-0.04
(-0.49%)
After-Hours: 20:00
Pharming Group Cash from Operations (Quarterly): -7.647M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -7.647M |
December 31, 2023 | 11.58M |
September 30, 2023 | 3.527M |
June 30, 2023 | -9.621M |
March 31, 2023 | -22.78M |
December 31, 2022 | 5.235M |
September 30, 2022 | 12.62M |
June 30, 2022 | 3.998M |
March 31, 2022 | 0.609M |
December 31, 2021 | 15.93M |
September 30, 2021 | 5.491M |
June 30, 2021 | 9.357M |
March 31, 2021 | 7.061M |
December 31, 2020 | 18.67M |
September 30, 2020 | 19.25M |
June 30, 2020 | 23.97M |
March 31, 2020 | 21.74M |
December 31, 2019 | 22.45M |
September 30, 2019 | 23.79M |
June 30, 2019 | 16.89M |
March 31, 2019 | 11.02M |
December 31, 2018 | 16.10M |
September 30, 2018 | 19.18M |
June 30, 2018 | 12.24M |
March 31, 2018 | -1.185M |
Date | Value |
---|---|
December 31, 2017 | 34.19M |
September 30, 2017 | 16.45M |
June 30, 2017 | 0.472M |
March 31, 2017 | -5.265M |
December 31, 2016 | 2.962M |
September 30, 2016 | -3.928M |
June 30, 2016 | -6.226M |
March 31, 2016 | -3.329M |
December 31, 2015 | -3.528M |
September 30, 2015 | -4.713M |
June 30, 2015 | -5.627M |
March 31, 2015 | -4.828M |
December 31, 2014 | 14.23M |
September 30, 2014 | -2.343M |
June 30, 2014 | -8.748M |
March 31, 2014 | -6.273M |
December 31, 2013 | 9.601M |
September 30, 2013 | 0.098M |
June 30, 2013 | -6.159M |
March 31, 2013 | -3.540M |
December 31, 2012 | 1.375M |
September 30, 2012 | -4.595M |
June 30, 2012 | -5.733M |
March 31, 2012 | -4.629M |
December 31, 2011 | -18.66M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-22.78M
Minimum
Mar 2023
23.97M
Maximum
Jun 2020
9.105M
Average
10.47M
Median
Cash from Operations (Quarterly) Benchmarks
uniQure NV | -60.58M |
ProQR Therapeutics NV | -16.44M |
Merus NV | -44.39M |
argenx SE | -- |
Pharvaris NV | -26.32M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 0.664M |
Cash from Financing (Quarterly) | -2.471M |
Free Cash Flow | -3.493M |
Free Cash Flow Per Share (Quarterly) | -0.1179 |
Free Cash Flow to Equity (Quarterly) | -4.194M |
Free Cash Flow to Firm (Quarterly) | -7.727M |
Free Cash Flow Yield | -0.52% |